Spur® Elute DEEPER CORONARY Study Completes Enrollment

Spur® Elute DEEPER CORONARY Study Completes Enrollment

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Sep 29, 2025-

DEEPER CORONARY study of Spur Elute retrievable scaffold system completes enrolment - Cardiovascular News

Reflow Medical has announced the completion of enrolment in the DEEPER CORONARY study. This pilot study evaluates the Spur Elute coronary sirolimus-eluting retrievable scaffold system as a primary treatment for in-stent restenosis (ISR) of the coronary arteries. Spur Elute is the first and only retrievable self-expanding scaffold with radially expandable spikes, combined with an integrated balloon, both of which are drug coated. It is designed t…

Reflow’s Pilot Study of Spur Elute Scaffold for ISR Completes Enrollment - Cardiac Interventions Today

September 29, 2025—Reflow Medical, Inc. announced the completion of enrollment in DEEPER CORONARY, a pilot study evaluating the company’s Spur Elute coronary sirolimus-eluting retrievable scaffold system as a primary treatment for in-stent restenosis (ISR) of the coronary arteries. The first-in-human study enrolled nine patients, who will be followed for 1 year after the procedure, noted the press release. According to the company, Spur Elute fe…